← Back to directory

D. Gareth Evans

Researcher Next ID · RN-021775

Researcher · Biochemistry, Genetics and Molecular Biology

Atrium Health Wake Forest Baptist

Winston-Salem, United Kingdom

Not currently recruitingFunding unknown
Works count
2,451
Citation count
136,840
H-index
183
i10-index
1,215

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
BRCA gene mutations in cancer
Neurofibromatosis and Schwannoma Cases
Genetic factors in colorectal cancer
Meningioma and schwannoma management
Global Cancer Incidence and Screening

Publications

  • Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

    JAMA Oncology · 2022 · https://doi.org/10.1001/jamaoncol.2021.6744

  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

    Genetics in Medicine · 2021 · https://doi.org/10.1038/s41436-021-01170-5

  • Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

    Nature Genetics · 2020 · https://doi.org/10.1038/s41588-020-0609-2

  • Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics · 2020 · https://doi.org/10.1038/s41588-019-0537-1

  • Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

    Genetics in Medicine · 2019 · https://doi.org/10.1038/s41436-019-0596-9

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    The American Journal of Human Genetics · 2018 · https://doi.org/10.1016/j.ajhg.2018.11.002

  • Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

    Human Mutation · 2018 · https://doi.org/10.1002/humu.23406

  • Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848

    The American Journal of Human Genetics · 2017 · https://doi.org/10.1016/j.ajhg.2017.12.001

  • Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

    JAMA · 2017 · https://doi.org/10.1001/jama.2017.7112

  • Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

    Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2016.69.4935

  • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

    New England Journal of Medicine · 2015 · 10.1056/nejmsr1501341

  • Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

    JAMA · 2015 · https://doi.org/10.1001/jama.2014.5985

  • DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

    PLoS Genetics · 2014 · https://doi.org/10.1371/journal.pgen.1004256

  • Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

    JNCI Journal of the National Cancer Institute · 2013 · 10.1093/jnci/djt095

  • Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

    PLoS Genetics · 2013 · https://doi.org/10.1371/journal.pgen.1003212

  • Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome

    Familial Cancer · 2013 · https://doi.org/10.1007/s10689-013-9674-3

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA)

    Cancer Epidemiology Biomarkers & Prevention · 2012 · https://doi.org/10.1158/1055-9965.epi-11-0775

  • Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

    Breast Cancer Research · 2011 · https://doi.org/10.1186/bcr3052

  • Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

    PLoS Biology · 2011 · https://doi.org/10.1371/journal.pbio.1001199

  • Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

    The Lancet · 2011 · 10.1016/s0140-6736(11)61049-0

  • Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

    Gut · 2010 · 10.1136/gut.2009.179804

  • Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service

    American Journal of Medical Genetics Part A · 2010 · 10.1002/ajmg.a.33139

  • Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

    Cancer Research · 2010 · https://doi.org/10.1158/0008-5472.can-10-1907

  • A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

    Nature Genetics · 2010 · https://doi.org/10.1038/ng.669

  • Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2

    Nature Genetics · 2009 · https://doi.org/10.1038/ng.354

  • A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3

    Nature Genetics · 2008 · 10.1038/ng.111

  • Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

    The American Journal of Human Genetics · 2008 · https://doi.org/10.1016/j.ajhg.2008.02.008

  • Genome-wide association study identifies novel breast cancer susceptibility loci

    Nature · 2007 · 10.1038/nature05887

  • PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

    Nature Genetics · 2006 · 10.1038/ng1959

  • Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

    Journal of Medical Genetics · 2006 · 10.1136/jmg.2006.045906

  • Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)

    The Lancet · 2005 · 10.1016/s0140-6736(05)66481-1

  • Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

    Clinical Cancer Research · 2005 · 10.1158/1078-0432.ccr-04-2424

  • Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

    Journal of Clinical Oncology · 2004 · 10.1200/jco.2004.04.188

  • Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

    The American Journal of Human Genetics · 2003 · 10.1086/375033

  • Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

    New England Journal of Medicine · 2002 · 10.1056/nejmoa012158

  • Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

    Nature Genetics · 2002 · 10.1038/ng879

  • Malignant peripheral nerve sheath tumours in neurofibromatosis 1

    Journal of Medical Genetics · 2002 · 10.1136/jmg.39.5.311

  • Epidemiology of Helicobacter pylori in an asymptomatic population in the United States

    Gastroenterology · 1991 · 10.1016/0016-5085(91)90644-z

Current projects

    No projects listed.